UBS Group
PHVS icon

UBS Group’s Pharvaris PHVS Stock Holding History

UBS Group’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
71,941
-65,793
-48% -$1.76M ﹤0.01% 4968
2025
Q4 		$3.82M Buy
137,734
+6,982
+5% +$168K ﹤0.01% 4306
2025
Q3 		$3.26M Buy
130,752
+127,009
+3,393% +$2.82M ﹤0.01% 4475
2025
Q2 		$65.9K Sell
3,743
-3,706
-50% -$59.7K ﹤0.01% 7553
2025
Q1 		$117K Buy
7,449
+6,404
+613% +$108K ﹤0.01% 6931
2024
Q4 		$20K Sell
1,045
-546
-34% -$11.2K ﹤0.01% 7868
2024
Q3 		$29.5K Buy
1,591
+1,424
+853% +$26K ﹤0.01% 7137
2024
Q2 		$3.14K Buy
+167
New +$3.4K ﹤0.01% 8253
2023
Q4 		– Sell
-50
Closed -$1.04K – 9759
2023
Q3 		$1.04K Sell
50
-1,250
-96% -$23K ﹤0.01% 8160
2023
Q2 		$19.7K Buy
1,300
+878
+208% +$8.49K ﹤0.01% 6875
2023
Q1 		$3.4K Sell
422
-2,378
-85% -$20.9K ﹤0.01% 8324
2022
Q4 		$31.5K Buy
+2,800
New +$14.7K ﹤0.01% 7189
2022
Q3 		– Sell
-799
Closed -$18K – 10781
2022
Q2 		$18K Buy
799
+71
+10% +$1.32K ﹤0.01% 7023
2022
Q1 		$13K Buy
728
+305
+72% +$5.38K ﹤0.01% 8067
2021
Q4 		$6K Sell
423
-231
-35% -$3.61K ﹤0.01% 9283
2021
Q3 		$12K Buy
+654
New +$11.2K ﹤0.01% 7779
2021
Q2 		– Sell
-32
Closed -$1K – 9704
2021
Q1 		$1K Buy
+32
New +$1.01K ﹤0.01% 8786

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

UBS Group's PHVS Position: Q1 2026 in Review

UBS Group reduced its Pharvaris (PHVS) stake by 48% in Q1 2026, selling an estimated $1.76M and leaving 71,941 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4968.

UBS Group first reported a position in PHVS in Q1 2021 and has held it in 17 quarters since. The position peaked at $3.82M in Q4 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • UBS Group held 71,941 shares of Pharvaris worth $2.03M as of Q1 2026.
  • UBS Group sold 65,793 Pharvaris shares in Q1 2026, an estimated $1.76M.
  • Pharvaris made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4968 holding.
  • UBS Group first reported a position in Pharvaris in Q1 2021 and has held it in 17 quarters since.
  • UBS Group's Pharvaris position peaked at $3.82M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.